Literature DB >> 18337115

Urocortins: emerging metabolic and energy homeostasis perspectives.

Yael Kuperman1, Alon Chen.   

Abstract

The effects of stress on energy balance and the involvement of the neuropeptide corticotropin releasing factor in modulating the anorexia of stress and sympathetic nervous system tone are well recognized. Currently, studies centered on the roles of the more recently described members of this family of ligands, the urocortins, and their preferred receptor, the corticotropin releasing factor type 2 receptor, suggest that they are important modulators of centrally controlled metabolic functions. In addition, urocortins also regulate fuel utilization in the periphery by acting locally within key metabolic tissues through autocrine and/or paracrine mechanisms. Recent findings have demonstrated that urocortin 2 and urocortin 3, by acting through their specific receptor in peripheral tissues, are novel modulators of glucose homeostasis and metabolic functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337115     DOI: 10.1016/j.tem.2007.12.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  30 in total

1.  Perifornical Urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis.

Authors:  Yael Kuperman; Orna Issler; Limor Regev; Ifat Musseri; Inbal Navon; Adi Neufeld-Cohen; Shosh Gil; Alon Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

2.  Involvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells.

Authors:  Hongxia Chao; Haochen Li; Rebecca Grande; Vitor Lira; Zhen Yan; Thurl E Harris; Chien Li
Journal:  Mol Endocrinol       Date:  2015-04-15

Review 3.  Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior.

Authors:  Andrey E Ryabinin; Michael M Tsoory; Tamas Kozicz; Todd E Thiele; Adi Neufeld-Cohen; Alon Chen; Emily G Lowery-Gionta; William J Giardino; Simranjit Kaur
Journal:  Alcohol       Date:  2012-03-22       Impact factor: 2.405

Review 4.  Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism.

Authors:  Emily G Lowery; Todd E Thiele
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

5.  Mass spectrometry-based neuropeptidomics of secretory vesicles from human adrenal medullary pheochromocytoma reveals novel peptide products of prohormone processing.

Authors:  Nitin Gupta; Steven J Bark; Weiya D Lu; Laurent Taupenot; Daniel T O'Connor; Pavel Pevzner; Vivian Hook
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

6.  Structural basis for hormone recognition by the Human CRFR2{alpha} G protein-coupled receptor.

Authors:  Kuntal Pal; Kunchithapadam Swaminathan; H Eric Xu; Augen A Pioszak
Journal:  J Biol Chem       Date:  2010-10-21       Impact factor: 5.157

7.  Posttranslational processing of human and mouse urocortin 2: characterization and bioactivity of gene products.

Authors:  Joan M Vaughan; Cynthia J Donaldson; Wolfgang H Fischer; Marilyn H Perrin; Jean E Rivier; Paul E Sawchenko; Wylie W Vale
Journal:  Endocrinology       Date:  2013-03-14       Impact factor: 4.736

8.  CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner.

Authors:  Mark O Huising; Talitha van der Meulen; Joan M Vaughan; Masahito Matsumoto; Cynthia J Donaldson; Hannah Park; Nils Billestrup; Wylie W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

9.  On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders.

Authors:  A Slominski
Journal:  Br J Dermatol       Date:  2009-02       Impact factor: 9.302

10.  Association of HPA axis-related genetic variation with stress reactivity and aggressive behaviour in pigs.

Authors:  Eduard Muráni; Siriluck Ponsuksili; Richard B D'Eath; Simon P Turner; Esra Kurt; Gary Evans; Ludger Thölking; Ronald Klont; Aline Foury; Pierre Mormède; Klaus Wimmers
Journal:  BMC Genet       Date:  2010-08-09       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.